Xianan Guo - Search Results

Year	Number of Results
2013	1
2018	1
2019	1
2020	2
2021	2
2022	4
2023	3
2024	1

1

TMEM151A Variants Cause Paroxysmal Kinesigenic Dyskinesia: A Large-Sample Study.

Tian WT, Zhan FX, Liu ZH, Liu Z, Liu Q, Guo XN, Zhou ZW, Wang SG, Liu XR, Jiang H, Li XH, Zhao GH, Li HY, Tang JG, Bi GH, Zhong P, Yin XM, Liu TT, Ni RL, Zheng HR, Liu XL, Qian XH, Wu JY, Cao YW, Zhang C, Liu SH, Wu YY, Wang QF, Xu T, Hou WZ, Li ZY, Ke HY, Zhu ZY, Zheng L, Wang T, Rong TY, Wu L, Zhang Y, Fang K, Wang ZH, Zhang YK, Zhang M, Zhao YW, Tang BS, Luan XH, Huang XJ, Cao L. Tian WT, et al. Mov Disord. 2022 Mar;37(3):545-552. doi: 10.1002/mds.28865. Epub 2021 Nov 24. Mov Disord. 2022. PMID: 34820915

2

Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition.

Guo X, Chen H, Zhou Y, Shen L, Wu S, Chen Y. Guo X, et al. Expert Opin Investig Drugs. 2022 Sep;31(9):933-944. doi: 10.1080/13543784.2022.2097067. Epub 2022 Jul 7. Expert Opin Investig Drugs. 2022. PMID: 35786092 Review.

3

Loss of FUT8 in renal tubules ameliorates ischemia-reperfusion injury-induced renal interstitial inflammation transition to fibrosis via the TLR3-NF-κB pathway.

Li Z, Hao J, Li L, Shen N, Wang D, Wang N, Wen X, Wang W, Qin B, Tang Q, Guo X, Song H, Du X, Yang F, Lin H. Li Z, et al. Among authors: guo x. FASEB J. 2023 Aug;37(8):e23091. doi: 10.1096/fj.202300623R. FASEB J. 2023. PMID: 37432656

4

First-line CDK4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis.

Guo X, Zhou Y, Zhang K, Lu W, Zhong X, Wu S, Shen L, Chen H, Chen Y. Guo X, et al. J Evid Based Med. 2024 Mar;17(1):106-118. doi: 10.1111/jebm.12571. Epub 2023 Dec 16. J Evid Based Med. 2024. PMID: 38102891

5

Positive association of serum FUT8 activity with renal tubulointerstitial injury in IgA nephropathy patients.

Yang N, Li LK, He H, Guo XN, Yuan XF, Li ZT, Wang WD, Qin BJ, Du XN, Zhang X, Chen SN, Lin HL. Yang N, et al. Immun Inflamm Dis. 2022 Sep;10(9):e686. doi: 10.1002/iid3.686. Immun Inflamm Dis. 2022. PMID: 36039648 Free PMC article.

6

Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2.

Wu S, Qi L, Chen H, Zhang K, He J, Guo X, Shen L, Zhou Y, Zhong X, Zheng S, Zhou J, Chen Y. Wu S, et al. Among authors: guo x. NPJ Breast Cancer. 2022 Jul 19;8(1):86. doi: 10.1038/s41523-022-00454-6. NPJ Breast Cancer. 2022. PMID: 35853885 Free PMC article.

7

Inhibition of core fucosylation limits progression of diabetic kidney disease.

Fang M, Kang L, Wang X, Guo X, Wang W, Qin B, Du X, Tang Q, Lin H. Fang M, et al. Among authors: guo x. Biochem Biophys Res Commun. 2019 Dec 10;520(3):612-618. doi: 10.1016/j.bbrc.2019.10.037. Epub 2019 Oct 14. Biochem Biophys Res Commun. 2019. PMID: 31623829

8

Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study.

Zhou Y, Guo X, Shen L, Liu K, Sun Q, Wang Y, Wang H, Fu W, Yao Y, Wu S, Chen H, Qiu J, Pan T, Deng Y. Zhou Y, et al. Among authors: guo x. Onco Targets Ther. 2023 Nov 16;16:939-960. doi: 10.2147/OTT.S434193. eCollection 2023. Onco Targets Ther. 2023. PMID: 38021447 Free PMC article.

9

The Phenotypic and Genetic Spectrum of Paroxysmal Kinesigenic Dyskinesia in China.

Huang XJ, Wang SG, Guo XN, Tian WT, Zhan FX, Zhu ZY, Yin XM, Liu Q, Yin KL, Liu XR, Zhang Y, Liu ZG, Liu XL, Zheng L, Wang T, Wu L, Rong TY, Wang Y, Zhang M, Bi GH, Tang WG, Zhang C, Zhong P, Wang CY, Tang JG, Lu W, Zhang RX, Zhao GH, Li XH, Li H, Chen T, Li HY, Luo XG, Song YY, Tang HD, Luan XH, Zhou HY, Tang BS, Chen SD, Cao L. Huang XJ, et al. Mov Disord. 2020 Aug;35(8):1428-1437. doi: 10.1002/mds.28061. Epub 2020 May 11. Mov Disord. 2020. PMID: 32392383

10

Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 163 patients.

Tian WT, Huang XJ, Mao X, Liu Q, Liu XL, Zeng S, Guo XN, Shen JY, Xu YQ, Tang HD, Yin XM, Zhang M, Tang WG, Liu XR, Tang BS, Chen SD, Cao L. Tian WT, et al. Mov Disord. 2018 Mar;33(3):459-467. doi: 10.1002/mds.27274. Epub 2018 Jan 22. Mov Disord. 2018. PMID: 29356177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year